7-113878447-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002711.4(PPP1R3A):​c.2645T>A​(p.Leu882His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.994 in 1,612,496 control chromosomes in the GnomAD database, including 796,312 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.97 ( 72160 hom., cov: 32)
Exomes 𝑓: 1.0 ( 724152 hom. )

Consequence

PPP1R3A
NM_002711.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.15

Publications

30 publications found
Variant links:
Genes affected
PPP1R3A (HGNC:9291): (protein phosphatase 1 regulatory subunit 3A) The glycogen-associated form of protein phosphatase-1 (PP1) derived from skeletal muscle is a heterodimer composed of a 37-kD catalytic subunit and a 124-kD targeting and regulatory subunit. This gene encodes the regulatory subunit which binds to muscle glycogen with high affinity, thereby enhancing dephosphorylation of glycogen-bound substrates for PP1 such as glycogen synthase and glycogen phosphorylase kinase. [provided by RefSeq, Jul 2008]
PPP1R3A Gene-Disease associations (from GenCC):
  • diabetes mellitus, noninsulin-dependent
    Inheritance: Unknown Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.8340702E-6).
BP6
Variant 7-113878447-A-T is Benign according to our data. Variant chr7-113878447-A-T is described in ClinVar as Benign. ClinVar VariationId is 1231102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.992 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002711.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP1R3A
NM_002711.4
MANE Select
c.2645T>Ap.Leu882His
missense
Exon 4 of 4NP_002702.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP1R3A
ENST00000284601.4
TSL:1 MANE Select
c.2645T>Ap.Leu882His
missense
Exon 4 of 4ENSP00000284601.3

Frequencies

GnomAD3 genomes
AF:
0.973
AC:
147975
AN:
152006
Hom.:
72121
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.914
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.985
Gnomad ASJ
AF:
0.986
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.968
Gnomad NFE
AF:
0.998
Gnomad OTH
AF:
0.972
GnomAD2 exomes
AF:
0.991
AC:
247592
AN:
249766
AF XY:
0.993
show subpopulations
Gnomad AFR exome
AF:
0.915
Gnomad AMR exome
AF:
0.990
Gnomad ASJ exome
AF:
0.986
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
0.998
Gnomad OTH exome
AF:
0.990
GnomAD4 exome
AF:
0.996
AC:
1454155
AN:
1460372
Hom.:
724152
Cov.:
73
AF XY:
0.996
AC XY:
723663
AN XY:
726546
show subpopulations
African (AFR)
AF:
0.912
AC:
30491
AN:
33442
American (AMR)
AF:
0.990
AC:
44140
AN:
44598
Ashkenazi Jewish (ASJ)
AF:
0.985
AC:
25722
AN:
26112
East Asian (EAS)
AF:
1.00
AC:
39672
AN:
39672
South Asian (SAS)
AF:
0.999
AC:
86162
AN:
86248
European-Finnish (FIN)
AF:
1.00
AC:
52440
AN:
52446
Middle Eastern (MID)
AF:
0.980
AC:
5644
AN:
5762
European-Non Finnish (NFE)
AF:
0.999
AC:
1110238
AN:
1111738
Other (OTH)
AF:
0.988
AC:
59646
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
375
751
1126
1502
1877
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21664
43328
64992
86656
108320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.973
AC:
148068
AN:
152124
Hom.:
72160
Cov.:
32
AF XY:
0.974
AC XY:
72414
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.914
AC:
37942
AN:
41512
American (AMR)
AF:
0.985
AC:
15009
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.986
AC:
3418
AN:
3468
East Asian (EAS)
AF:
1.00
AC:
5149
AN:
5150
South Asian (SAS)
AF:
1.00
AC:
4826
AN:
4828
European-Finnish (FIN)
AF:
1.00
AC:
10632
AN:
10632
Middle Eastern (MID)
AF:
0.966
AC:
284
AN:
294
European-Non Finnish (NFE)
AF:
0.998
AC:
67843
AN:
67974
Other (OTH)
AF:
0.972
AC:
2053
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
201
402
604
805
1006
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.993
Hom.:
46000
Bravo
AF:
0.970
TwinsUK
AF:
0.999
AC:
3704
ALSPAC
AF:
0.998
AC:
3848
ESP6500AA
AF:
0.912
AC:
4018
ESP6500EA
AF:
0.998
AC:
8578
ExAC
AF:
0.990
AC:
120164
EpiCase
AF:
0.997
EpiControl
AF:
0.996

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Type 2 diabetes mellitus Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PPP1R3A-related disorder Benign:1
Oct 29, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.82
T
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.010
DANN
Benign
0.27
DEOGEN2
Benign
0.050
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.00084
N
LIST_S2
Benign
0.091
T
MetaRNN
Benign
0.0000018
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.22
N
PhyloP100
-2.1
PrimateAI
Benign
0.28
T
PROVEAN
Benign
1.1
N
REVEL
Benign
0.0070
Sift
Benign
0.29
T
Sift4G
Benign
0.28
T
Polyphen
0.0010
B
Vest4
0.032
MPC
0.052
ClinPred
0.016
T
GERP RS
-4.0
Varity_R
0.047
gMVP
0.13
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2974938; hg19: chr7-113518502; COSMIC: COSV99495035; COSMIC: COSV99495035; API